Nautilus Biotechnology

Delivering on the Promise of the Human Proteome

[Nautilus Biotechnology @NautilusBio]

Nautilus’ Iterative Mapping Early Access Program gives you the unique opportunity to employ our novel single-molecule proteomic analysis method and platform for your research.

Join Now: https://t.co/2Ci3SgSl7P

Our initial fee-for-service offering through the program enables you to be among the first to deeply explore the human tau protein by quantifying up to 768 full-length tau proteoforms in your samples of interest. Studying these previously inaccessible forms of the tau protein may be critical to understanding neurodegenerative diseases as well as developing novel biomarkers and precision medicines.

Even if your project doesn’t involve tau, we welcome prompt completion of the form on the page linked here as spots in the program will be limited. We look forward to working with you!

[Nautilus Biotechnology @NautilusBio]

Today at #ASMS2026, Nautilus Senior Director of Scientific Affairs and Alliance Management, Andreas Huhmer, will be giving a poster presentation (#644) covering the "High Accuracy Single-Molecule Quantification of Tau Proteoforms across Isoforms and Phosphorylation Sites."

Drop by to discover the quantitative benefits of single-molecule proteomics on the Nautilus Voyager™ Platform.

[Nautilus Biotechnology @NautilusBio]

If you're at #ASMS and want to learn more about single-molecule proteomics enabled by Iterative Mapping on the Nautilus Voyager™ Platform, be sure to chat with Jamie Rose Kuhar, Megan Showalter, and Amber (Kessinger) Faust all of whom are pictured here and will be available throughout the conference.

In addition, Andreas Huhmer will be giving a poster presentation this Thursday (Poster #644). He'll share data covering the "High Accuracy Single-Molecule Quantification of Tau Proteoforms across Isoforms and Phosphorylation Sites."

Proteoform analysis will be a critical part of the future of biology. Drop by Andreas' poster to learn more and to discover why the Nautilus Voyager Platform is uniquely suited to advancing this proteoform-powered future.

#ASMS2026 #Proteomics #Proteoforms

[Nautilus Biotechnology @NautilusBio]

ASMS 2026 is just around the corner!

Drop by our poster (#644) or meet with a Nautilus representative at the event to discover how you can be one of the first to integrate the Nautilus Voyager™ Platform into your workflows.

Set up meeting here:

https://t.co/ornGBmHGEE

[Nautilus Biotechnology @NautilusBio]

In the coming weeks, we'll be publishing the latest edition of the “Proteomics and neuroscience” eBook! This update will focus on how researchers are already using the Nautilus Voyager™ Platform to reveal hidden neurobiology.

Read our latest blog post for a sneak peek and to learn how you can sign up to receive your copy as soon as it's available.

https://t.co/9Y0LpUoX81

[Nautilus Biotechnology @NautilusBio]

We're excited to attend the 2026 ASMS Conference (May 31- June 4). Nautilus representatives will be at the event to discuss how you can integrate single-molecule proteomics into your workflows.

At this year's conference, we're particularly excited to invite you to join the Iterative Mapping Early Access Program. By participating in the program, you'll gain exclusive access to the Nautilus Voyager™ Platform and will be one of the first to use the platform for targeted proteoform analyses and broadscale proteomics.

If you'd like to discuss a project or have questions about the Nautilus Voyager™ Platform, please set up a meeting with us at the conference through the link below.

https://t.co/3Wy6Zzg9sw

[Nautilus Biotechnology @NautilusBio]

If you're at Tau Global 2026, keep an eye out for these folks to discover how you can measure tau proteoforms with single-molecule accuracy, sensitivity, and reproducibility on the Nautilus Voyager™ Platform.

And if you're not at the conference, be sure to visit our website to learn how you can join the Iterative Mapping Early Access Program and be one of the first to achieve single-molecule clarity in your explorations of biological function.
https://t.co/Z0pCgMHsdW

📸Pictured below from left to right:
Amber (Kessinger) Faust, Sheri Wilcox Ph.D., Andreas Huhmer Ph.D., Jamie Rose Kuhar, Ph.D.

[Nautilus Biotechnology @NautilusBio]

The Tau Global Conference starts tomorrow in Washington DC!

Keep an eye out for Sheri Wilcox, Andreas Huhmer, Amber Faust, and Jamie Rose Kuhar throughout the conference and be sure to drop by the following posters to explore Novel tau proteoform data generated on the Nautilus Voyager™ Platform:

📊 Iterative Mapping of Tau Proteoforms Uncovers Regional Heterogeneity in Alzheimer's Disease (P-47)
🗓️ Thursday, May 14th, from 8:30am -4pm
🗣️ Andreas Huhmer Ph.D., Senior Director of Scientific Affairs and Alliance Management, Nautilus Biotechnology

📊 IVS10+16 MAPT Mutation: Phenotyping in Cortical and Midbrain Organoids (P-31)
🗓️ Friday, May 15th, from 8:30am-4pm
🗣️ Taylor Bertucci Ph.D., Principal Investigator, Regenerative Research Foundation/Neural Stem Cell Institute

[Nautilus Biotechnology @NautilusBio]

We hope to see you at Tau Global 2026 in Washington D.C. this Thursday and Friday (May 14 and 15th).

If you'd like to learn how you can use Iterative Mapping and the Nautilus Voyager™ Platform to quantify up to 768 tau proteoforms in your samples of interest, be sure to drop by our poster (#47) or set up a meeting with a Nautilus representative by clicking the link below:

https://t.co/yx4426W8Ai

[Nautilus Biotechnology @NautilusBio]

Nautilus VP of Scientific Engagement, Sheri Wilcox Ph.D., will be presenting at Georgetown University on Wednesday May 13th. If you're in town, drop by to discover how you can achieve single-molecule insights with Iterative Mapping on the Nautilus Voyager™ Platform.

And to find all of our upcoming events, be sure to visit our events page:

https://t.co/kY7ZgVwSnY

[Nautilus Biotechnology @NautilusBio]

We're excited to attend the 2026 Tau Global Conference (May 14-15)!

Nautilus representatives will be at the event to discuss how you can integrate single-molecule proteomics into your workflows. At this year's conference, we're particularly excited to invite you to join our Iterative Mapping Early Access Program. By participating in the program, you'll gain exclusive access to the Nautilus Tau Proteoforms Assay enabling the quantification of up to 768 tau proteoforms!

If you'd like to discuss a project or have questions about the Nautilus Voyager™ Platform, please set up a meeting with us at the conference through the link below. We'll also have a poster at the event and will share poster details soon!

https://t.co/yx4426W8Ai

[US HUPO @us_hupo]

🔬 Meet panelist #3:
Parag Mallick (@paragmallick), co-founder of @NautilusBio and Stanford professor. Hear how he turned a bold proteomics idea into a NASDAQ-listed company and how IP plays a key role. April 27.

📅 Register now: https://t.co/dfiOAsjbew

#USHUPO #Proteomics

[Nautilus Biotechnology @NautilusBio]

Find more information about the Iterative Mapping Early Access Program and it's first offering, the Tau Proteoforms Assay, here:
https://t.co/jDiNmeZTuV

[Nautilus Biotechnology @NautilusBio]

🗓️We're expanding our presence at conferences, roadshows, and more as we recruit innovative scientists like you to incorporate the Nautilus Voyager™ Platform into their workflows and join the Iterative Mapping Early Access Program. To see where we'll be in the coming months, check out our Events Page:

https://t.co/kY7ZgVwSnY

✍️And if you'd like to work with us to set up an event at your organization, fill out the form at the bottom of the page, and we'll be in touch.

We hope to see you soon!

[Nautilus Biotechnology @NautilusBio]

This Thursday April 23rd at 11:40am PT, Nautilus Co-Founder and CEO Sujal Patel will be speaking on a panel at the @Biocom #ConvergeSummit about the role AI tools are playing in the biotech industry.

The panel will include:

▶️Jacob Berlin, PhD - Co-Founder & CEO of @Terray_Tx
▶️Kexin Huang, PhD - Co-Founder & CEO of @phylo_bio
▶️Michelle Lee - Founder & CEO of @medra_ai
▶️Amir M. - Director of Business Development at @thernabio
▶️Dylan Reid - Managing Director at @ZettaVentures

We look forward to a fascinating discussion!

https://t.co/Tpt9AyRJh0

[Nautilus Biotechnology @NautilusBio]

In our latest blog post, we cover some of the highlights from a recent episode of the Translating Proteomics podcast featuring Professor Olga Vitek from Northeastern University.

Read the post to discover how statistics and AI can help us achieve a more holistic understanding of biology and listen to the podcast episode for even more insights.

https://t.co/enh2cR3gSv

#TranslatingProteomics #Podcast #Proteomics #Statistics #AI #ArtificialIntelligence

[Biocom @Biocom]

Interested in exploring the latest in AI tools for life science? Look no further than this engaging session with leaders from @medra_ai @NautilusBio, Phylo, @Terray_Tx @thernabio and @ZettaVentures at our #ConvergeSummit on April 23. Learn more: https://t.co/21osw0VsHH

[Nautilus Biotechnology @NautilusBio]

The latest Nautilus Newsletter is live. Check it out to:

🔵 Meet the Nautilus Voyager™ Platform
🔵 Learn more about new customers, collaborators, and company leaders
🔵 Discover the latest from US HUPO 2026
🔵 Find Nautilus at upcoming events

https://t.co/NrMFZihQBp

[Nautilus Biotechnology @NautilusBio]

With the successful launch of the Artemis II and all the SCIENCE IN SPACE featured in "@projecthailmary," now is a great time to explore all the fascinating things we can learn through OMCIS IN SPACE.

On a recent episode of the Translating Proteomics podcast, we sat down with Afshin Beheshti, Professor of Surgery, Director of the Center for Space Biomedicine, and Associate Director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh, to discuss the impacts of microgravity and space radiation on the body, how scientists are studying these changes using omics technologies, and ways to mitigate their effects.

In this blog post, we highlight some of the key takeaways from the conversation.

Read the full post:
https://t.co/8aNLgW8V9f

Many thanks to Jennifer Tsang, Ph.D. Tsang for help with this post!

[Nautilus Biotechnology @NautilusBio]

If you'd like to become an Early Access Program customer, sign up here:
https://t.co/jDiNmeZTuV

[Nautilus Biotechnology @NautilusBio]

In case you missed the announcement of Baylor College of Medicine as our first Early Access Program customer, check out this great article from Adam Bonislawski at GenomeWeb!

https://t.co/zzd6aRIuiF